Clinical trial
Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
NCT02003131 is registered in ClinicalTrials.gov with Translational Biosciences as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Feasibility Study of Mesenchymal Trophic Factor (MTF) for Treatment of Osteoarthritis
- Lead sponsor
- Translational Biosciences
- Phase
- Phase 1/2
- Overall status
- Withdrawn
- Start date
- December 31, 2013
- Completion date
- June 30, 2019
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
osteoarthritis of the knee